NeoGenomics, Inc. NEO
16.83 USD +0.34 (+2.06%)
At closeNov 3, 2026, 4:01 PM EST
16.83 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
16.57 Day range 17.34
7.07 52-week range 20.15
- YTD
- +43.11%
- 1 year
- +72.09%
Analyst view
Consensus: buy
Buy
Price target (mean) 23.40 +39.0% upside
Now 16.83
- Target (low)
- 19.00
- Target (mean)
- 23.40
- Target (high)
- 35.00
Ratings (0m) 11 8 buy · 3 hold · 0 sell
- Strong buy2
- Buy6
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.06455 | 0.05 – 0.08 | 0.06 | +7.6% | 210.60M | +10.8% | 11 |
| Next quarter | 0.054 | 0.01 – 0.09 | 0.01 | +440.0% | 206.43M | +10.6% | 10 |
| Current year | 0.204 | 0.18 – 0.22 | 0.12 | +70.0% | 808.20M | +11.1% | 10 |
| Next year | 0.31455 | 0.22 – 0.39 | 0.204 | +54.2% | 886.92M | +9.7% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 29, 2026 | BTIG | Reiterated | Buy | Buy |
| Oct 6, 2026 | StoneX | Maintained | Buy | Buy |
| Oct 6, 2026 | Needham | Maintained | Buy | Buy |
| Oct 6, 2026 | BTIG | Upgrade | Neutral | Buy |
| Jul 29, 2026 | Needham | Maintained | Buy | Buy |
| Jul 24, 2026 | Benchmark | Maintained | Buy | Buy |
| Apr 29, 2026 | Benchmark | Upgrade | Hold | Buy |
| Apr 29, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 29, 2026 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Feb 24, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 17, 2026 | Needham | Maintained | Buy | Buy |
| Jan 12, 2026 | Needham | Reiterated | Buy | Buy |
| Sep 12, 2025 | TD Cowen | Maintained | Buy | Buy |
| Sep 2, 2025 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 29, 2025 | Needham | Maintained | Buy | Buy |
| Aug 4, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 30, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 29, 2025 | William Blair | Downgrade | Outperform | Market Perform |
| Jul 29, 2025 | Needham | Maintained | Buy | Buy |
| May 6, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| May 1, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 30, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Apr 30, 2025 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Apr 29, 2025 | Needham | Maintained | Buy | Buy |
| Apr 17, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Feb 26, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 19, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| Feb 19, 2025 | Needham | Maintained | Buy | Buy |
| Jan 28, 2025 | Goldman Sachs | Maintained | Buy | Buy |